plasmodium falciparum sporozoite
Cell therapyexperimental
Clinical trial activity
4 trials · 9 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Apr 1, 2009 (NCT01001650)
Timeline
2000s
- Jan 1, 2009
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Plasmodium falciparumImmunity, active
Plasmodium falciparum immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- plasmodium falciparum sporozoite
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03882528 | Phase 1 | Mar 4, 2019 | United States Army |
| NCT02739763 | Phase 1 | May 1, 2016 | Kenya Medical Research Institute, Pwani University, Sanaria Inc., University of Cambridge, University of Oxford, Wellcome Trust |
| NCT01465048 | N/A | Oct 1, 2011 | Sanaria Inc., University of Oxford |
| NCT01001650 | Phase 1 | Apr 1, 2009 | PATH, Sanaria Inc., United States Navy |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (9)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Sanaria Inc. | For profit | 3 | 1 | 2 | 2009 |
| University of Oxford | Academic/Hospital | 2 | 2 | 2 | 2011 |
| Kenya Medical Research Institute | Academic/Hospital | 1 | 0 | 1 | 2016 |
| PATH | Academic/Hospital | 1 | 0 | 1 | 2009 |
| Pwani University | Academic/Hospital | 1 | 0 | 1 | 2016 |
| United States Army | Government | 1 | 1 | 1 | 2019 |
| United States Navy | Government | 1 | 0 | 1 | 2009 |
| University of Cambridge | Academic/Hospital | 1 | 0 | 1 | 2016 |
| Wellcome Trust | Academic/Hospital | 1 | 0 | 1 | 2016 |
9 organizations
Page 1 / 1